1.88
전일 마감가:
$1.70
열려 있는:
$1.78
하루 거래량:
144.86K
Relative Volume:
0.67
시가총액:
$21.76M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-3.5472
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
+18.24%
1개월 성능:
+39.26%
6개월 성능:
+55.37%
1년 성능:
+49.21%
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TXMD
Therapeuticsmd Inc
|
1.88 | 19.68M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 개시 | Guggenheim | Buy |
| 2019-10-17 | 개시 | H.C. Wainwright | Buy |
| 2019-04-30 | 재개 | Noble Capital Markets | Outperform |
| 2018-06-15 | 개시 | JP Morgan | Overweight |
| 2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 재개 | Jefferies | Buy |
| 2016-11-22 | 개시 | Oppenheimer | Outperform |
| 2016-11-07 | 재개 | Guggenheim | Buy |
| 2016-04-04 | 개시 | Goldman | Buy |
| 2015-12-08 | 재확인 | Jefferies | Buy |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-09-21 | 재확인 | Jefferies | Buy |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2014-07-08 | 개시 | FBR Capital | Outperform |
| 2014-04-17 | 재확인 | Noble Financial | Buy |
| 2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Announces Pricing of Offering of Common Stock - AOL.com
TherapeuticsMD, Inc. (TXMD) 5.48% in After-hours: What’s Driving the Move? - Stocks Telegraph
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc Stock Analysis and ForecastCandlestick Trading Patterns & Low Risk Trading Plans - earlytimes.in
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Falls 7.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
What drives TherapeuticsMD Inc 29TA stock priceSupport Zone Identification & High Return Stock Ideas - earlytimes.in
Is TherapeuticsMD Inc. stock a buy before product launchesWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentalsAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targets2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Will TherapeuticsMD Inc. (29TA) stock outperform energy sector in 2025Portfolio Update Summary & AI Enhanced Trading Signals - newser.com
Will TherapeuticsMD Inc. (29TA) stock hit Wall Street targetsPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
How TherapeuticsMD Inc. (29TA) stock responds to bond marketMarket Volume Summary & Consistent Return Investment Signals - newser.com
Why TherapeuticsMD Inc. stock is seen as undervaluedQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
Trend analysis for TherapeuticsMD Inc. this week2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
How TherapeuticsMD Inc. (29TA) stock compares with tech leadersGap Up & Community Consensus Stock Picks - newser.com
Is TherapeuticsMD Inc. (29TA) stock a contrarian opportunityMarket Performance Report & Reliable Breakout Forecasts - newser.com
Will TherapeuticsMD Inc. stock see insider buyingAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):